Sinclair and IS Pharm agree merger

Skin treatments supplier Sinclair Pharma and speciality drugs group IS Pharma have reached agreement on a merger that was announced in February.IS Pharma shareholders will receive 2.68 Sinclair shares for every one of their shares.The merger intends to combine Sinclair's distribution operations in France, Germany, Italy and Spain with IS's in Britain and Ireland to create "a strong European business with direct presence in the major markets and partnerships in emerging growth markets."